As a transcription factor, MED1 is an important part of mega transcription factor-bound in trans enhancers, which can promote estrogen (E2)-mediated improvements in the transcriptional efficiency of downstream genes through ERα, thus promoting the growth of cancer cells (Liu et al., 2014). Here, MED1 is linked to cancer.